Parathyroid hormone plus alendronate--a combination that does not add up

Editorial

Sundeep Khosla. N Engl J Med. 2003.

. 2003 Sep 25;349(13):1277-9.

doi: 10.1056/NEJMe038143. Epub 2003 Sep 20.

No abstract available

Comment in

Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
Miller PD. Miller PD. N Engl J Med. 2004 Jan 8;350(2):189-92; author reply 189-92. N Engl J Med. 2004. PMID: 14714279 No abstract available.

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH. Neer RM, et al. N Engl J Med. 2001 May 10;344(19):1434-41. doi: 10.1056/NEJM200105103441904. N Engl J Med. 2001. PMID: 11346808 Clinical Trial.
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.
Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ; PaTH Study Investigators. Black DM, et al. N Engl J Med. 2003 Sep 25;349(13):1207-15. doi: 10.1056/NEJMoa031975. Epub 2003 Sep 20. N Engl J Med. 2003. PMID: 14500804 Clinical Trial.
The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM. Finkelstein JS, et al. N Engl J Med. 2003 Sep 25;349(13):1216-26. doi: 10.1056/NEJMoa035725. Epub 2003 Sep 20. N Engl J Med. 2003. PMID: 14500805 Clinical Trial.